Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects
Men Over Age 75 Shouldn’t Be Screened For Prostate Cancer, Task Force Says
Quality Of Care Varies Widely For Prostate Cancer, Study Says
Prostatectomy Improves Outcome In Some Men
Risk of Relapse Continues After Five Years of Therapy
Two Breast Cancer Screening Methods Found Equivalent
Zometa Prevents Bone Loss In Premenopausal Women
Risk Assessment Key In Long-Term Treatment
Survey Finds Misconceptions About Cancer Worldwide
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO
